Position in MCRB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$12,055
-$3,485 QoQ
Shares Held
1,528
-12.8% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 36 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MCRB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FMR LLC holds $61,424,667,384 across 370 Biotechnology names. MCRB ranks #304 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
5,231,452 | $4,853,584,218 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
15,023,962 | $4,522,663,276 | |
| 3 | MRNA |
Moderna, Inc.
|
51,859,891 | $3,631,748,165 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
81,020,390 | $2,867,311,601 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
12,200,422 | $2,284,895,029 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,631,956 | $1,953,067,789 | |
| 7 | INSM |
INSMED Inc
|
16,143,583 | $1,721,228,815 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,418,197 | $1,642,111,277 |
All Filings in MCRB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $12,055 | 1,528 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $15,540 | 1,752 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,890 | 1,740 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $36,209 | 1,882 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,985,300 | 268,704 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $15,322,601 | 21,889,432 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $18,125,519 | 21,811,697 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $21,622,967 | 22,857,260 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $16,447,226 | 22,717,164 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $17,532,198 | 22,651,419 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $27,144,010 | 19,388,580 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $45,769,046 | 19,230,692 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $91,897,145 | 19,185,208 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $107,227,966 | 18,911,458 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $104,657,061 | 18,688,761 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $119,480,905 | 18,610,733 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $63,802,157 | 18,601,212 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $98,810,397 | 13,877,865 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $114,762,992 | 13,777,070 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $95,754,182 | 13,757,785 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $308,119,891 | 12,919,073 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $252,859,057 | 12,280,673 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $277,746,038 | 11,336,573 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $303,409,594 | 10,717,400 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $27,332,281 | 5,742,076 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $21,954,593 | 6,149,746 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||